| Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical … JM Dumonceau, M Polkowski, A Larghi, P Vilmann, M Giovannini, ... Endoscopy 43 (10), 897-912, 2011 | 364 | 2011 |
| Evaluation of Ki-67 index in EUS–FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors T Hasegawa, K Yamao, S Hijioka, V Bhatia, N Mizuno, K Hara, H Imaoka, ... Endoscopy 46 (01), 32-38, 2014 | 204 | 2014 |
| Prospective clinical study of EUS-guided choledochoduodenostomy for malignant lower biliary tract obstruction K Hara, K Yamao, Y Niwa, A Sawaki, N Mizuno, S Hijioka, M Tajika, ... Official journal of the American College of Gastroenterology| ACG 106 (7 …, 2011 | 196 | 2011 |
| Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese … S Hijioka, W Hosoda, K Matsuo, M Ueno, M Furukawa, H Yoshitomi, ... Clinical Cancer Research 23 (16), 4625-4632, 2017 | 190 | 2017 |
| Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience S Haba, K Yamao, V Bhatia, N Mizuno, K Hara, S Hijioka, H Imaoka, ... Journal of gastroenterology 48, 973-981, 2013 | 175 | 2013 |
| Prospective clinical study of endoscopic ultrasound-guided choledochoduodenostomy with direct metallic stent placement using a forward-viewing echoendoscope K Hara, K Yamao, S Hijioka, N Mizuno, H Imaoka, M Tajika, S Kondo, ... Endoscopy 45 (05), 392-396, 2013 | 156 | 2013 |
| A multimodality test to guide the management of patients with a pancreatic cyst S Springer, DL Masica, M Dal Molin, C Douville, CJ Thoburn, B Afsari, L Li, ... Science translational medicine 11 (501), eaav4772, 2019 | 144 | 2019 |
| Comparison of endoscopic submucosal dissection and endoscopic mucosal resection for large colorectal tumors M Tajika, Y Niwa, V Bhatia, S Kondo, T Tanaka, N Mizuno, K Hara, ... European journal of gastroenterology & hepatology 23 (11), 1042-1049, 2011 | 137 | 2011 |
| Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers Y Shimizu, H Yamaue, H Maguchi, K Yamao, S Hirono, M Osanai, ... Pancreas 42 (5), 883-888, 2013 | 130 | 2013 |
| Endoscopic ultrasonography-guided biliary drainage: Who, when, which, and how? K Hara, K Yamao, N Mizuno, S Hijioka, H Imaoka, M Tajika, T Tanaka, ... World journal of gastroenterology 22 (3), 1297, 2016 | 127 | 2016 |
| Familial pancreatic cancer: Concept, management and issues H Matsubayashi, K Takaori, C Morizane, H Maguchi, M Mizuma, ... World journal of gastroenterology 23 (6), 935, 2017 | 121 | 2017 |
| Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable … T Ogura, K Yamao, K Hara, N Mizuno, S Hijioka, H Imaoka, A Sawaki, ... Journal of gastroenterology 48, 640-646, 2013 | 121 | 2013 |
| Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency H Yanai, K Nakamura, S Hijioka, A Kamei, T Ikari, Y Ishikawa, E Shinozaki, ... The journal of biochemistry 148 (1), 85-92, 2010 | 111 | 2010 |
| Can EUS-guided FNA distinguish between gallbladder cancer and xanthogranulomatous cholecystitis? S Hijioka, MA Mekky, V Bhatia, A Sawaki, N Mizuno, K Hara, W Hosoda, ... Gastrointestinal endoscopy 72 (3), 622-627, 2010 | 102 | 2010 |
| Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer … M Ozaka, Y Matsumura, H Ishii, Y Omuro, T Itoi, H Mouri, K Hanada, ... Cancer chemotherapy and pharmacology 69, 1197-1204, 2012 | 98 | 2012 |
| Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the … S Hirono, Y Shimizu, T Ohtsuka, T Kin, K Hara, A Kanno, S Koshita, ... Journal of gastroenterology 55, 86-99, 2020 | 90 | 2020 |
| Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin … JC Yao, J Strosberg, N Fazio, ME Pavel, P Ruszniewski, E Bergsland, ... Annals of Oncology 29, viii467-viii468, 2018 | 90 | 2018 |
| JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis T Ito, T Masui, I Komoto, R Doi, RY Osamura, A Sakurai, M Ikeda, ... Journal of gastroenterology 56 (11), 1033-1044, 2021 | 86 | 2021 |
| Evaluation of modified glasgow prognostic score for pancreatic cancer: a retrospective cohort study H Imaoka, N Mizuno, K Hara, S Hijioka, M Tajika, T Tanaka, M Ishihara, ... Pancreas 45 (2), 211-217, 2016 | 86 | 2016 |
| Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms JC Yao, J Strosberg, N Fazio, ME Pavel, E Bergsland, P Ruszniewski, ... Endocrine-related cancer 28 (3), 161-172, 2021 | 78 | 2021 |
Y. YATABE在 ncc.go.jp 的电子邮件经过验证
